Stay updated on Nivolumab with Varlilumab in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with Varlilumab in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with Varlilumab in Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Locations section reorganized to consolidate study sites under a single Locations list by state (Arizona, Florida, Georgia, Illinois, Kansas, Minnesota, Missouri, New Hampshire, New York, Texas). Per-state location subsections (Arizona Locations, Florida Locations, etc.) were removed, and a revision tag v3.3.3 was added.
    Difference
    0.8%
    Check dated 2025-12-23T20:43:19.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Minor site revision from v3.2.0 to v3.3.2; it does not affect study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T10:10:39.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Added the 'Last Update Posted (Estimated)' label under Study Record Dates to indicate the most recent update timing. Removed the operating-status notice about a lapse in government funding.
    Difference
    0.4%
    Check dated 2025-11-18T03:26:59.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    Added Study Record Dates entries: estimated study completion date 2026-10-24 and last update posted 2025-11-10. Several April 2025 update entries were removed.
    Difference
    0.2%
    Check dated 2025-11-10T21:48:18.000Z thumbnail image
  7. Check
    54 days ago
    Change Detected
    Summary
    Screenshots indicate only administrative updates (such as last update posted date and results posting date) with no changes to core study content (design, eligibility criteria, arms, or outcomes). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T18:39:30.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    The page now adds a general government operating-status notice and a new medical term (Malignant lymphoma, large B-cell, diffuse) with a new revision v3.2.0, while removing the previous term T-cell/histiocyte rich large B cell lymphoma and its v3.1.0 revision.
    Difference
    2%
    Check dated 2025-10-06T04:27:50.000Z thumbnail image

Stay in the know with updates to Nivolumab with Varlilumab in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with Varlilumab in Lymphoma Clinical Trial page.